Literature DB >> 16326710

Mitochondrial reactive oxygen species in mice lacking superoxide dismutase 2: attenuation via antioxidant treatment.

Karl J Morten1, Brian A C Ackrell, Simon Melov.   

Abstract

Mice that lack the mitochondrial form of superoxide dismutase (SOD2) incur severe pathologies and mitochondrial deficiencies, including major depletion of complex II, as a consequence of buildup of endogenous reactive oxygen species (Melov, S., Coskun, P., Patel, M., Tuinstra, R., Cottrell, B., Jun, A. S., Zastawny, T. H., Dizdaroglu, M., Goodman, S. I., Huang, T. T., Miziorko, H., Epstein, C. J., and Wallace, D. C. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 846-851 and Li, Y., Huang, T. T., Carlson, E. J., Melov, S., Ursell, P. C., Olson, J. L., Noble, L. J., Yoshimura, M. P., Berger, C., Chan, P. H., Wallace, D. C., and Epstein, C. J. (1995) Nat. Genet. 11, 376-381). These problems can be greatly attenuated or rescued by synthetic antioxidant treatment, such as with the catalytic antioxidant EUK189 (Hinerfeld, D., Traini, M. D., Weinberger, R. P., Cochran, B., Doctrow, S. R., Harry, J., and Melov, S. (2004) J. Neurochem. 88, 657-667). We have used heart mitochondria from sod2 null mice to better understand mitochondrial reactive oxygen species production both in the absence of SOD2 and following in vivo antioxidant treatment. Isolated heart mitochondria from 5-day-old sod2 null animals respiring on the complex II substrate succinate exhibited statistically significant higher levels of mitochondrial O2* (157%, p < 0.01) but significantly less H2O2 (33%, p < 0.001) than wild type littermates. Treatment of sod2 nullizygous mice with EUK189 proportionately increased the levels of complex II and H2O2. Increased production of O2* resulting from complex II normalization had no effect on steady state levels due to the rapid conversion to H2O2, a process presumably aided by the presence of the EUK189, an SOD mimetic.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16326710     DOI: 10.1074/jbc.M509261200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell death.

Authors:  E-M Schweikert; A Devarajan; I Witte; P Wilgenbus; J Amort; U Förstermann; A Shabazian; V Grijalva; D M Shih; R Farias-Eisner; J F Teiber; S T Reddy; S Horke
Journal:  Cell Death Differ       Date:  2012-03-23       Impact factor: 15.828

2.  Tissue-specific splicing of an Ndufs6 gene-trap insertion generates a mitochondrial complex I deficiency-specific cardiomyopathy.

Authors:  Bi-Xia Ke; Salvatore Pepe; David R Grubb; Jasper C Komen; Adrienne Laskowski; Felicity A Rodda; Belinda M Hardman; James J Pitt; Michael T Ryan; Michael Lazarou; Jane Koleff; Michael M H Cheung; Joseph J Smolich; David R Thorburn
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

3.  Paraoxonase 2 deficiency alters mitochondrial function and exacerbates the development of atherosclerosis.

Authors:  Asokan Devarajan; Noam Bourquard; Susan Hama; Mohamad Navab; Victor R Grijalva; Susan Morvardi; Catherine F Clarke; Laurent Vergnes; Karen Reue; John F Teiber; Srinivasa T Reddy
Journal:  Antioxid Redox Signal       Date:  2010-09-06       Impact factor: 8.401

4.  Mitochondrial oxidative stress in aortic stiffening with age: the role of smooth muscle cell function.

Authors:  Rui-Hai Zhou; Aleksandr E Vendrov; Igor Tchivilev; Xi-Lin Niu; Kimberly C Molnar; Mauricio Rojas; Jacqueline D Carter; Haiyan Tong; George A Stouffer; Nageswara R Madamanchi; Marschall S Runge
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-12-22       Impact factor: 8.311

Review 5.  Role of Platelet-Derived Transforming Growth Factor-β1 and Reactive Oxygen Species in Radiation-Induced Organ Fibrosis.

Authors:  Jasimuddin Ahamed; Jeffrey Laurence
Journal:  Antioxid Redox Signal       Date:  2017-07-05       Impact factor: 8.401

6.  Antioxidants improve early survival of cardiomyoblasts after transplantation to the myocardium.

Authors:  Martin Rodriguez-Porcel; Olivier Gheysens; Ramasamy Paulmurugan; Ian Y Chen; Karen M Peterson; Jürgen K Willmann; Joseph C Wu; Xiangyang Zhu; Lilach O Lerman; Sanjiv S Gambhir
Journal:  Mol Imaging Biol       Date:  2009-12-15       Impact factor: 3.488

Review 7.  Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention.

Authors:  Diana F Silva; J Eva Selfridge; Jianghua Lu; Lezi E; Sandra M Cardoso; Russell H Swerdlow
Journal:  Adv Pharmacol       Date:  2012

8.  Design and synthesis of manganese porphyrins with tailored lipophilicity: investigation of redox properties and superoxide dismutase activity.

Authors:  Dorothée Lahaye; Kannan Muthukumaran; Chen-Hsiung Hung; Dorota Gryko; Júlio S Rebouças; Ivan Spasojević; Ines Batinić-Haberle; Jonathan S Lindsey
Journal:  Bioorg Med Chem       Date:  2007-08-19       Impact factor: 3.641

9.  Role of PON2 in innate immune response in an acute infection model.

Authors:  Asokan Devarajan; Noam Bourquard; Victor R Grijalva; Feng Gao; Ekambaram Ganapathy; Jitendra Verma; Srinivasa T Reddy
Journal:  Mol Genet Metab       Date:  2013-07-15       Impact factor: 4.797

10.  Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculature.

Authors:  Lei Chen; Robert A Yokel; Bernhard Hennig; Michal Toborek
Journal:  J Neuroimmune Pharmacol       Date:  2008-10-01       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.